Table 5.
Contraction (mN) upon exposure to K+ (40 mM) before exposure to pharmacological inhibitors
| WT | Cx37−/− | Cx40−/− | Cx40+/− |
|---|---|---|---|
| 1.8 ± 0.2 | 2.8 ± 0.3* | 3.9 ± 0.3*** | 1.8 ± 0.2 |
N = 6–10. * or *** p < 0.05 or 0.001 vs WT
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.